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ABSTRACT

Zaidi, Syed Anwar Hyder. M.S.B.M.E, Department of Biomedical, Industrial and Human
Factors Engineering, Wright State University, 2016. Optical Redox Imaging of Metabolic
Activity

Fluorescence imaging can be used to determine tissue metabolism, which is an indication
of the cellular functionality. Metabolic contrast is useful for the early detection of several
medical conditions such as cancer, diabetes, lung diseases etc.
This study aims to use fluorescence imaging to quantify NADH and FAD, which are
cellular metabolic indicators. A parameter known as Redox ratio, can be used to study
metabolic state of several tissue types and disease states.
To quantify the Redox ratio, three fluorescence imaging systems were optimized to
measure the fluorescence signal from NADH and FAD. The first system was a camera
based model suitable for laboratory and clinical settings. The second and third were
compact versions of the same instrument. The systems were characterized and brain cancer
cells were measured using the camera based system and the compact model, which resulted
in a similar Redox ratio.
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Introduction and Background
1.1 Introduction
Mitochondria play a very essential role in a cellular metabolism. Dysfunction in
mitochondria may lead to several diseases as shown in the Figure 1.1 [1-2]. Pioneer works
of Warburg showed the involvement of mitochondria in a tumor cell [3]. Since then, a
number of studies were performed to investigate the presence of mitochondrial
dysfunction[1] in many conditions such as aging[4,5], neurodegenerative diseases like
Parkinson’s and Alzheimer’s [6-8], tissue damage post stroke[9] , spinal cord injury[10],
cardiovascular diseases[11], liver and kidney[12,13], diabetes and obesity[14-16],
cancer[17-25] and many other medical conditions.

Figure 1.1: Mitochondrial dysfunction
Adapted for Mayevsky et al, 2009 [2]
1

Pioneer works of Chance et al showed a relation between function of mitochondria in
health and disease by quantifying NADH redox state in mitochondria [26-28]. Since then
several studies were performed in various pathophysiological conditions to study
metabolic changes in experiments, animals and patients [29-30].

1.1.1 Cancer
Cancer can be one the of the consequences of mitochondrial dysfunction. Cancer is defined
as an abnormal growth or uncontrolled division of cells [31]. There are several types of
cancer which including breast, oral, brain, prostate and many more. Figure 1.2 shows the
cancer cases and mortality rate in both developed and underdeveloped countries.

Figure 1.2: Cancer statistics [32]
2

1.1.1.1 Brain Cancer
Brain tumors can be benign or malignant and only the latter is termed as brain cancer.
Cancerous cells compete with the healthy cells and take up their space, blood and nutrients
to grow and spread [33]. The exact cause of brain cancer is not clearly [33]. Not all brain
tumors show symptoms and some are detected only when a CT or MRI scan is done [33].
Common symptoms include headache, weakness, nausea, changes in intellectual capacity
or emotional response gradually, difficulty in walking and in speech, but some of these are
not limited to brain tumors alone and can be missed easily [33]. CT and MRI are generally
performed for the diagnosis.
If a tumor is suspected, then a biopsy will be performed followed by pathophysiological
examination to detect the presence of cancer. Biopsy of the brain is usually one piece which
is enough for diagnosis, however removing aby brain tissue for a biopsy can cause further
brain damage and might also cause infection.

Figure 1.3: Brain cancer statistics [34]
3

Generally, treatment of neuronal tumors involves surgery for the removal of the tumor
followed by radiation or chemotherapy to remove any remaining cancerous cells [33].

1.1.2 Motivation
As per the 2012 census there were about 14.1 million cancer cases around the world [35].
Around 256,213 cases of brain tumors [36] have been reported worldwide in 2012. As per
2016 census, 1,685,210 new cancer cases and 595,690 cancer deaths have occurred in The
United States, making it the major cause of death in 21 states [37]. Approximately 78,000
brain cancer diagnoses have been reported in the U.S. Hence there is an urgent need to
develop a device which can accurately identify the presence of cancer noninvasively in its
early stages to avoid mortality.
Presence of cancer alters metabolism of the cell which is associated with cell growth and
proliferation [38-39]. Usually cancer cells have increased metabolism which is used as a
tool for investigating or detecting cancer in the body [40]. A wide range of clinical
instruments have already been developed which can accurately identify the presence of
cancer but are expensive and require the patient to visit the hospital for diagnoses. Thus,
an instrument should be developed which is portable (Wearable), low cost and user friendly
which could potentially make cancer diagnoses easy and detectable in its early stages. The
aim of this study is to develop a portable, inexpensive and wireless device capable of
measuring the fluorescence emitted by fluorophores such as Nicotinamide Adenine
Dinucleotide (NADH) [41] and Flavin Adenine Dinucleotide (FAD) [42] which are
involved in cellular metabolic pathways.

4

1.2 Background of Redox Ratio
1.2.1 Mitochondria
Mitochondria are found in all Eukaryotic cells where they play a large role in cellular
metabolism and energy generation. Structure of mitochondria is shown in Figure 1.4.
Overall, mitochondria have several important functions, the most important functions
being oxidation of food materials and cellular respiration [43]. Cellular respiration is the
process where the breakdown of complex food molecules through oxidation within the cell
leads to the release of considerable amounts of energy [44]. Complex molecule compounds
known as respiratory substrates are oxidized during this process. Carbohydrates are the
preferred substrates, but proteins and fats can be used as well [45].

Figure 1.4: Mitochondria structure [46]
When respiratory substrates are broken down in the presence of oxygen it is called aerobic
respiration. All the energy is not released free into the cell in a single step. It is released in
5

a series of reactions which are controlled by enzymes [47]. The chemical energy thus
obtained is held in the form of Adenosine triphosphate (ATP) [48], which can then be
utilized as a source of energy for the cell [49-50]. Energy released by oxidation in
respiration is used to synthesize ATP and not used directly. The amount of energy that is
produced depends on the quantity of oxygen present inside the cell [51]. This energy is
produced through a process called the electron transport chain. Redox reactions such as
respiration extracting energy through this process.
Energy trapped in ATP is utilized in various processes for the organism and the carbon
components produced during respiration is used for bio synthesis of various other
molecules in the cells [52]. ATP synthase is an important enzyme providing energy for the
cell through the synthesis of ATP. ATP is formed from a reversible reaction of Adenosine
diphosphate (ADP) and Inorganic Phosphate (PI) popularly known as ATP-ADP cycle.

ADP + PI +free ATP

Thus, Mitochondria are also often referred to as miniature biochemical factories wherein
respiratory substrates and other food stuff are completely broken down and oxidized to
carbon dioxide and water. Energy generated during this process is stored as reduced
coenzymes and prosthetic groups which later undergo oxidation and form ATP which is
rich in energy. ATP generated out of mitochondria is used in many energy requiring
processes [53].

6

1.2.2 Electron Transport Chain
As mentioned in the previous section, energy is produced in the cell through a process
called the electron transport chain, which is responsible for the generation of energy within
the cells.

The electron transport chain is a chemical series of electron donation and electron
acceptance. A continuous transportation of electrons form an electron donor to a more
electronegative acceptor takes place. This process continues to the most electronegative
acceptor at the end of the chain [54]. Finally, the energy is released by the conversion of
ATP from ADP as mentioned in the previous section 1.2.1. The entire process is
called oxidative phosphorylation.

There are two proteins in the mitochondrial inner membrane, NADH and FAD, which get
oxidized by complex chemical reactions resulting in the release of a proton across the
membrane. A Figure of electron transport chain is shown in Figure 1.5.

Figure 1.5: Electron transport chain [54-55]
7

1.2.3 Mitochondrial Oxidative Stress
In the process of electron transport chain, a small number of electrons do not participate in
this process and directly leak to oxygen [54]. This leads to the formation of free radical
which cause a phenomenon known as oxidative stress.

Oxidative stress is defined as the excess or deficiency of oxygen in the cell, caused by the
imbalance of reactive oxygen produced in the cell and the system’s inability to repair the
resulting damage caused by it [54,56]. Disturbance in the normal redox reaction in the cell
produces peroxides and free radicals which can have toxic effects [57], which can have a
damaging effect on the cell [54]. Therefore, for the proper functionality of the cell, quantity
of oxygen present in the cell and its surroundings play a very vital role [58-60].

Figure 1.6: Mitochondrial dysfunction and death of the cell [63]
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Oxidative stress is responsible for causing several diseases and aging in a cell [61-63]. The
amount of energy produced in the cell is a function of the quantity of oxygen present in the
cell. Oxidative stress, the imbalance of oxygen present in the cell, can cause various
malfunctioning in the cell and can also lead to cell death [54]. The Figure 1.6 shows the
mitochondrial dysfunction and ultimately the death of the cell [63].

Oxidative stress is seen in a number of neurological diseases such as Amyotrophic Lateral
Sclerosis [64], Parkinson's disease [65], Alzheimer's disease [66], Huntington's disease
[67], and Multiple sclerosis[68-69].

Several diseases are caused by poor functioning of the cell due to the improper balance of
oxygen in the mitochondria which accelerates cell death [70]. Thus, determining the
amount of oxygen present inside the cell can prove a very useful tool for feedback of the
health of the cell. This is very important in situations relating to mitochondrial dysfunction
and oxidative stress [54]. In such situations, oxidation state (redox state) can be used to
determine the health of the tissue.

1.3 Optical Imaging
In this section, optical imaging, especially fluorescence imaging is explained.

1.3.1 Optical Imaging
Imaging performed using light as tool is termed as optical imaging. This imaging technique
has emerged in the past decades as a strong tool for determining the anatomy [71],
physiology [72], metabolic [73], and molecular function [74] of the tissue under
9

investigation [54]. In this research, measurement of redox ratio can be done without using
harmful radiation on the subject [54]. Moreover, optical imaging techniques have the
advantage of being non-invasive, inexpensive and being very sensitive for detection
purposes [75]. The one disadvantage of optical imaging is that penetration depth limiting
access to tissue anatomy is less when compared to other imaging modalities like MRI, CT
etc. [76].

Optical imaging can use a wide spectral range covering ultraviolet light to infrared light.
For this research, we use ultra violet (UV) light as the excitation wavelength for both
NADH and FAD. When the photons from the optical sources interact with the tissue, they
either are absorbed or scattered.

1.3.2 Light Transport in Tissue
A common model for tissue imaging is the semi-infinite geometry, as shown in Figure 1.7.
In semi-infinite geometry, there is a single interface, typically with air above and tissue
below. When the light is incident on the surface, multiple processes can occur. Some
percentage will undergo specular reflection and never enter the tissue. For photons that
enters the tissue, they will either be scattered in random directions and or absorbed
depending upon the wavelength used and the property of the tissue. Thus, there are two
main optical parameters that define the light transport in tissue: absorption and scattering
parameters. I will be introducing briefly these parameters in the next sections.
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Figure 1.7: Interaction of light with the tissue

1.3.2.1 Light Absorption
The relation between absorption of light in a non-scattering, absorbing medium was first
given by Bourger in 1729 and then by Lambert in 1760 [77]. Per this study when light with
an intensity 𝐈𝐎 passes through a cuvette having a thickness d then the light obtained at the
other end will have a lower intensity comparatively [77].

Figure 1.8: Absorption of light in a non-scattering medium [77]
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The absorption of light in tissue is due to various chromophores present in the body such
as water, oxy-hemoglobin (HBO2), deoxy-hemoglobin (HHB), lipids, porphyrins,
melanin, NADH and Flavin’s, collagen, elastin, and lipo-pigments depending on the
wavelength range we are investigating [54]. In the Near Infrared (NIR) wavelength region,
the main absorption occurs due to oxy-hemoglobin (HbO2), and deoxy-hemoglobin (Hb)
chromophores. Thus, for tissue oxygenation studies, this wavelength range is commonly
used.

The Figure 1.9 shows the absorption spectrum of HHB and HBO2

Figure 1.9: Absorption Spectra of a oxy and deoxy hemoglobin[78]

1.3.2.2 Light Scattering
Light Scatter in a tissue because the cells and cellular organelles that make up a tissue have
a mismatched refractive index. [79]. When the refractive index changes between various
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organelles within the cells, which account for a large portion of solid content of the tissue,
scattering occurs [77]. In the visible and near-infrared wavelengths, scattering is the major
mechanism in the propagation of light through the tissue. Even in thin tissue, photons are
likely to scatter multiple times before reaching the boundary [77]. Scattering causes the
photons to travel a greater distance within a tissue thereby increasing the probability of the
photon getting absorbed which is shown in the Figure 1.10 [77]

Figure 1.10: Scattering of light [77]
Scattering is affected by several factors namely age, tissue oxygenation, and wavelength
of light [80]. For instance, in brain scattering increases with age, from birth to adulthood.
This occurs because as people age there is a two-fold increase in lipid and protein content.
In addition, the lipid in white matter, is increased by seven folds [81].

In biological tissue, light scatters multiple times and is characterized by a term known as
the reduced scattering coefficient (µ𝐬 ′). Reduced scattering coefficient is the reciprocal of
the total distance travelled by the photon before it gets completely randomized.

Due to variation in the size of cancer cells, there is a difference in the reduced scattering
coefficient between normal and cancerous cells [82].
13

1.3.2.3 Penetration Depth
In fluorescence spectroscopy, the light source and detector are generally placed on the
surface of the tissue, therefore primarily superficial information is collected. The
penetration depth is low because of two factors. First, fluorescence is a weak signal. This
means the source and detector are typically placed very close to each other to detect the
signal. Light that reaches the detector travels a “banana curve”, and as Figure 1.11 shows,
the separation between the source and detector influences the penetration depth. The depth
can be increased by increasing the source-detector separation but that would limit the signal
detected. Thus, there is a tradeoff between intensity of collected light and penetration
depth.

Figure 1.11: Penetration depth in smaller source detector separation (S-D small) and large
source detector separation (S-D large)
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The second factor affecting the penetration depth of light in tissue is the choice of
wavelength. As discussed in previous sections, shorter wavelength light tends to undergo
more absorption and scattering events, limiting the penetration depth. For fluorescence
spectroscopy, a shorter wavelength is used in most studies which further reduces the
penetration depth [83-85]. The relationship between penetration depth and wavelength is
shown in the Figure 1.12 [86]

Figure 1.12: Penetration depth as a function of wavelength [86]

1.3.3 Fluorescence Imaging
In this section the principles of fluorescence imaging will be discussed.

1.3.3.1 Mechanism of Fluorescence Imaging
Fluorescence is defined as the process wherein a fluorophore absorbs an excitation photon
and then emits a lower energy photon. [87]. The process of fluorescence is divided into
two stages namely the Excitation state and the Fluorescence emission state.
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Excitation: In this process a photon of energy called excitation energy is supplied to the
fluorophore by means of a light source (lamp, laser, light emitting diode, etc.), promoting
the molecule to jump to higher energy state as shown in Figure 1.13. Each fluorophore has
specific excitation and emission wavelengths where more absorption and emission occurs.

The process of fluorescence can be depicted by the Figure below

Figure 1.13: Stages of fluorescence [54,88]

An important parameter of every fluorophore is the fluorescence quantum yield. This
parameter is defined as the ratio of excitation photons to emission photons.

Fluorescence emission: The fluorophore returns to the ground stage by emitting a photon
of energy called emission energy. Photon energy is inversely related to the wavelength, or
directly related to the frequency of the light. Due to the dissipation of energy that occurred
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in the excited state, the emitted energy will be lower than the absorbed energy and the
wavelength of the fluorescence photon will be longer. The separation between excitation
and emission wavelength is known as Stokes shift, which is shown in Figure 1.14.

Figure 1.14: Stokes shift [54,89]

In vivo fluorescence gets affected by factors such as (i) movement artifacts (ii) Blood
oxygenation changes (iii) Variation in tissue absorption properties (iv) Tissue blood
volume variation [90]. Work has been done to nullify their effect for more accurate
measurement. For instance, movement artifacts can be corrected by making proper contact,
effects of absorption can be nullified by the subtraction technique [91-92], correction in
blood volume can be done by taking measurements on thin slices of the imaging tissue [93]
or by using the reflected light [94].

Early works of Chace et al and others showed that it was possible to link intrinsic
mitochondrial fluorophores to metabolism [95-105]. Fluorescence imaging, can be used to
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determine the metabolism of cells which can be used as tool to determine tissue
functionality.

1.3.3.2 Intrinsic Mitochondrial Fluorophores
Only a few fluorophores involved in cellular metabolic process are auto-fluorescent and
these can be used to study the metabolism of the tissue [54]. These fluorophores include
tryptophan, collagen, NADH, Flavin’s, and porphyrins [54]. As discussed earlier, NADH
and FAD are essential in mitochondrial metabolic activity and play a very important part
of the electron transport chain. Therefore, NADH and FAD fluorescence can be used to
study the oxidation state (redox state) of the mitochondria [106].

NADH is fluorescent in its reduced state and gives no fluorescence in oxidized form
whereas FAD is fluorescent in its oxidized form. We use a parameter known as redox ratio
to measure the metabolic state of the tissue and mitochondrial redox. The fluorescent
signals emitted from these fluorophores can be used as indicators of tissue vitality and
metabolism [107-109].

NADH has its peak excitation at 340nm (ultraviolet) and peak emission at 460nm (blue).
FAD on the other hand has two excitation wavelengths. One is at 340nm (ultraviolet) and
the other is at 448nm (blue) while the peak emission of FAD is at 520nm (green) as shown
in Figure 1.15.
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Figure 1.15: Excitation and emission wavelengths of NADH and FAD [110-111]

The NADH redox ratio is defined as the ratio of concentration of NADH to the summation
of concentration of FAD and NADH.
𝐂𝐎𝐍𝐂𝐄𝐍𝐓𝐀𝐑𝐓𝐈𝐎𝐍 𝐎𝐅 𝐍𝐀𝐃𝐇

NADH REDOX RATIO (R.R) = 𝐂𝐎𝐍𝐂𝐄𝐍𝐓𝐑𝐀𝐓𝐈𝐎𝐍 𝐎𝐅 𝐅𝐀𝐃+𝐂𝐎𝐍𝐂𝐄𝐍𝐓𝐑𝐀𝐓𝐈𝐎𝐍 𝐎𝐅 𝐍𝐀𝐃𝐇

(1.1)

Whereas, FAD redox ratio is defined as the ratio of concentration of FAD to the summation
of concentration of FAD and NADH.

FAD REDOX RATIO (R.R) =

𝐂𝐎𝐍𝐂𝐄𝐍𝐓𝐀𝐑𝐓𝐈𝐎𝐍 𝐎𝐅 𝐅𝐀𝐃
𝐂𝐎𝐍𝐂𝐄𝐍𝐓𝐑𝐀𝐓𝐈𝐎𝐍 𝐎𝐅 𝐅𝐀𝐃+𝐂𝐎𝐍𝐂𝐄𝐍𝐓𝐑𝐀𝐓𝐈𝐎𝐍 𝐎𝐅 𝐍𝐀𝐃𝐇

(1.2)

Because of important role played by these intrinsic mitochondrial fluorophores,
fluorescence imaging techniques has widely been used in biomedical research to study the
path-physical state of tissues [112-113], diagnose and/or monitor various diseases in heart
[114-115], kidney [116-117], liver [118], lung [107], skeletal muscles [119], cervix [120]
and brain [121].
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1.3.3.3 Applications of Fluorescence Imaging

As mentioned in the previous section, fluorescence imaging can be used for several
applications. A few of them are discussed in this section.

1.3.3.3.1 Brain Application
Mayevsky and Chance et al detected the fluorescence emission from the brain in various
conditions such as Anoxia, Ischemia etc. [29,122-124]. Their study concluded that Redox
ratio is the best way to evaluate mitochondrial function and tissue oxygen balance.

Fluorescence is used to study the changes occurring during brain stimulation. The study
was done by observing the NADH changes occurring due to cortical and ischemic change
during myocardial infarction [125]. Changes occurring in NADH signal can be used to
determine the metabolic changes [126]. Redox ratio can also be used to differentiate
between normal and cancer tissues in the brain and the study concluded that normal brain
tissue had higher FAD redox (FAD/FAD+NADH) compared to a cancer tissue [127]. The
reason for this being FAD gives fluorescence in oxidized form and NADH in reduced form.

1.3.3.3.2 Other Applications
Fluorescence from NADH and FAD can be used to differentiate between normal oral
keratinocytes and squamous carcinoma cells form various origin [128]. Detection of FAD
fluorescence can be used diagnose the presence of malignant oral mucosa since the cancer
region would have no FAD fluorescence emission [129].
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FAD redox is another parameter which can be used to detect oral malignancy [130]. It was
seen that normal cells and post treated cancer had more redox ratio in comparison to the
cancer cells. NADH and FAD can be used to detect cancer in neck and head area. Pauli et
also conclude that out of all endogenous fluorophores only NADH and FAD could
effectively differentiate between normal and cancer cells [131].

FAD Redox ratio can be used to differentiate normal tissue from cancer tissue in breast
biopsy’s [132]. FAD redox can also be used to differentiate between (aggressive) and less
metastatic (indolent) tissues in the breast [133]. Tryptophan to NADH ratio was also used
to discriminate normal, aggressive and non-aggressive cancer tissues in the breast. The
study concluded that the ratio was maximum for aggressive followed by less aggressive
cancer tissue and was least for normal tissue [134].
NADH redox (NADH/FAD) can be used to study changes in a rat’s perfused lung [135].
The ratio can be used to evaluate the pulmonary ischemia-reperfusion on lung tissue [136].
NADH redox can also be used to evaluate the condition of respiratory chain in a rat’s lungs
due to ischemia, hypoxia and Ischemia-reperfusion [107].

Fluorescence emitted by NADH and FAD can be used to differentiate normal, benign and
cancer tissue in prostate [137]. NADH fluorescence can used to determine the presence of
cancer in prostate tissue. It was seen that cancer tissue had more NADH fluorescence in
comparison to normal tissue [138]. By recording the emission at various excitation
wavelengths of NADH, an excitation- emission matrix can be constructed which can be
used to detect the presence of cancer in prostate tissue.
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Fluorescence emitted by NADH and FAD to investigate the presence of retinal pigmentosa
in mice [139]. Fluorescence of the two fluorophores can be used to determine the effects
of oxidative on mitochondrial redox in salt sensitive hypertension [140]. NADH
fluorescence can be used to differentiate between normal and cancerous bronchial tissue
[141]. NADH and FAD fluorescence can be used to study the photo aging process [142].
Metabolic state of the tissue based on auto fluorescence can be used to discriminate
between normal and cancer cells of the bladder [143].

1.4 Discussion
In the next chapter (Chapter 2) instrumentation and results of standard bench top camera
based systems will be explained in detail which is more suitable for Laboratory and Clinical
environment. There is also a need for combat and wireless device
In chapter 3 and chapter 4, instrumentation and results of compact systems will be
explained in detail.
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Instrumentation and Results of Camera
Based Model
2.1 Introduction
The first design was made looking at relevant literature, suitable for clinical and Lab
environment. This model provides high resolution images.

2.2 Instrumentation `
This section deals with sources and the detectors which are generally used for the design
of a fluorescence measurement device. All the source and detectors, along with their pros
and cons would be discussed in this section

2.2.1 Light Sources
The two common light sources which are used in optical instrumentation is a Laser diode
or a Light Emitting Diode (LED).
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2.2.1.1 Light Emitting Diode
Light emitting diode knows as LED’s are inexpensive, efficient and rugged [144]. They
are also available in number of wavelength ranges. Their only disadvantage is that they
have a wide spectral bandwidth (~20nm to ~60nm FWHM) and this can cause problems in
sensitive optical measurements where precise wavelength is required. In the case of
fluorescence measurements, a light source need not have high precision in wavelength
fluorophore has an excitation spectrum which is a wide and thus precision is not important.
Thus, LED’s are the ideal light sources for Fluorescence measurements.

2.2.1.2 Laser Diodes
Laser diodes are of two types namely single mode(SM) and multimode(MM) laser diode.
A SM has a smaller core radius than a MM laser. SM laser supports larger bandwidth than
a SM laser. A SM laser has lower signal losses compared to a MM laser. A SM laser are
more coherent than a MM laser. Both SM and MM laser are expensive and are chosen
depending upon type of application.

2.2.2 Detector Sources
The common light sources used in optical instrumentation are the PIN diodes, Avalanche
Photo Diode(APD), Photo Multiplier Tube(PMT), Spectrometer and Multispectral camera.

2.2.2.1 Pin Diodes
PIN diodes are very inexpensive and have a good quantum efficiency and dynamic range
[144]. Most of the PIN diodes have peak sensitivity in the 600nm -800nm range. They do
not have very high sensitive as they do not have an internal amplifier but this can be
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designed. They are usually used in application where sensitivity is not very important and
for shorter source and detector separation [144].

2.2.2.2 APD
Avalanche photo diodes are comparatively more sensitive than PIN diodes but they tend to
have a smaller dynamic range [144]. They have an in-build amplifier which tend to increase
their sensitivity. These are expensive than PIN diodes and they require a high voltage
supply for their operation. They are used in applications where the source-detector
separation distance is large.

2.2.2.3 PMT
Photo multiplier tube and APD have about the same sensitivity and dynamic range. PMT’s
can provide a farther more gain compared to a APD. The operating voltage is even higher
for a PMT when compared to a APD. The disadvantage of PMT is that it that they are
highly sensitive to supply voltage fluctuations, their gain depends on spectra and their
linearity is poor [144].

2.2.2.4 Spectrometer
A spectrometer is a device which collects the light, separates the light based on their
wavelength and displays the intensity values at specific wavelengths. A spectrometer can
have a desired spectral response as this depends on the groove density which can be altered.
The optical resolution (wavelength) can also be varied by varying the opening slit of a
spectrometer. A spectrometer is very sensitive device but is expensive compared to PMT
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and APD. As a spectrometer gives a complete spectrum of a wide range of wavelengths,
thus it is a commonly used in fluorescence applications.

2.2.2.5 Multispectral Camera
A multispectral camera is like a spectrometer as it captures the imaging surface and
provides the intensity at a specific wavelength within an image. It is equal or has a greater
sensitivity than a spectrometer. A multispectral camera is the most expensive detecting
module. Most of multispectral cameras are equipped with a filter mechanism which can be
used and only a desired range of wavelength can be measured which eliminated the use of
additional optical filters. The main advantage of using a camera is that it can take the image
from a greater separation distance and provide accurate results. Another advantage of the
camera is that it provides a complete image of imaging surface unlike point measurements
in other detecting modules.

2.3 Camera Based Module
In this section the Light source unit and the light detector unit of the camera based model
will be explained in detail.

2.3.1 Light Source Unit (LSU)
2.3.1.1 LED
The light source chosen for the camera based model was a high-power LED from Mightex.
The wavelength chosen was 365nm as this was capable of exciting both NADH and FAD.
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The product number of this LED is LCS-0365-02-22. The specification of the LED is given
in the Table 2.1.
PARAMETER

VALUE

WAVELENGTH

365nm

OPERATING CURRENT

500mA

OPERATING VOLTAGE

3.8V

OUTPUT POWER

80mW

Table 2.1: Specifications of LED (Camera model)

2.3.1.2 LED Driver
The LED driver used to run the LED was SLC series LED driver from Mightex. The part
number of this driver is SLC-SA04-US. The LED driver is connected to P.C by means of
USB or a RS 232 interface. The LED’s cathode and anode are connected to the driver as
marked and the desired supply current is varied by means of a software. By varying the
supply current, optical power of the LED could be varied. The specifications of the LED
driver are given in the Table 2.2.
Table 2.2: Specifications of LED Driver (Camera model)
PARAMETER

VALUE

SUPPLY VOLTAGE

9-12V

SUPPLY CURRENT

<4000mA

DRIVING VOLTAGE (max)

Supply voltage-0.5V

CURRENT RESOLUTION

12 bit
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2.3.2 LED Testing
The most important testing for a source used for optical applications is its power or stability
testing. It is very important for the source to be stable as variation in its power can lead to
false diagnoses. For instance, at a certain optical power a certain amount of fluorescence
intensity is expected. Due to instable power, if the optical power of the LED falls below its
normal value then the emitted fluorescence will also be low leading to false readings. Thus,
it is very important that the source be highly stable. In this experiment the current was set
to give a power of around 55mW.

Figure 2.1: Power stability of the LED (Camera based)
The mean and standard deviation from the LED stability test is shown in the Table 2.3.
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Table 2.3: Specifications of LED Driver (Camera model)
PARAMETER

VALUE

MEAN

55mW

STANDARD DIVIATION

220nW

2.3.2 Light Detector Unit (LDU)
The detector used to detect fluorescence in the camera based module was a Nuance
Multispectral Camera from Perkin Elmer. The camera has a USB interface with the P.C
and the images are taken using a Multispectral Imaging software. The camera can capture
images in both RGB mode and fluorescence mode depending upon the type of application.
The resolution of the camera is 14 bit and various binning and acquisition times can be
used to capture the image. The filter cube in the camera acts like a filter and can be set to
pass a desired range of wavelengths. The specifications of camera are given in Table 2.4.
Table 2.4: Specifications of the Multispectral Camera
PARAMETER

VALUE

SUPPLY VOLTAGE

5V DC

WAVELENGTH RANGE

400nm- 700nm

CAMERA RESOLUTION

14 bit (4096 intensity levels)

OPTICAL RESOLUTION

10nm

ACQUISTION TIME

10ms – 7s

BINNING

1x1, 2x2, 4x4

FILTER CUBE RANGE

10nm-full range
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2.3.2.1 Detector Testing
Testing the detector is essential to see if the device is calibrated and is working accurately.
As a device becomes old calibration is required so that the detection is precise. The
Multispectral Camera used in the design was tested by means of a detector card from
Thorlabs Inc (Part no: VRC2). The purpose of using this detector card was because of its
absorption and emission property. This was like fluorescence excitation and emission and
was the best way to test the device. The absorption and emission of the detector card from
Thorlabs is shown in the Figure 2.2.

Figure 2.2: The absorption and emission of the detector card (Thorlabs.com)
https://www.thorlabs.com/newgrouppage9.cfm?objectgroup_id=296&pn=VRC2#3218

The absorption wavelength used for detector testing was a 532nm Laser pointer from EBay. The distance between the detector card and camera was around 22 cm. A camera Lens
was used to focus the camera on the detector card.

30

Figure 2.3: Excitation light from the laser pointer and its spectrum (Filter: 480-580nm)

Figure 2.4: Emission light from the Detector card and its spectrum (Filter: 580-720nm)
The result (Figures 2.3 and Figure 2.4) obtained using the camera was very like the
specification sheet from Thorlabs Inc which show that the camera was calibrated and
accurate.

2.3.3 Experimental Setup
The setup used for fluorescence detection was simple and straight forward. The light from
the LED was collimated onto the imaging surface at a small angle so that it does not
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obstruct the camera’s imaging path. The distance between the LED and the imaging surface
was about 10cm. The emitted fluorescence was detected by the camera placed at 27cm
from the imaging surface. The camera was equipped with a tunable filter cube which could
pass desired range of wavelengths and stop unwanted wavelengths. A camera Lens was
also attached in front of the camera to focus the camera onto the imaging surface. The
complete setup of the camera based model used for all the experiments is shown in the
Figure 2.5.

Figure 2.5: Block Diagram of Camera Based Model Setup
A screen shot of Multispectral Imaging software used to capture images in all these
experiments is shown in the Figure 2.6
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Figure 2.6: Multispectral Imaging software

2.4 Phantom Experiment
In this section the phantom experiment conducted using the camera based model will be
explained in detail.

2.4.1 Experimental Procedure
The phantom experiment was done to test the linearity of NADH and FAD using the
camera based model with increasing concentration. Four concentrations of NADH and
FAD were made and placed in a 96 well palette, the LED at 365nm was illuminated on the
four wells having different concentrations to excite NADH and FAD. Initially the
reflectance at 365nm was taken to eliminate the effects of improper illumination and then
the emission spectra was captured. The fluorescence was corrected for reflectance, image
processing was performed and finally a linearity curve was plotted. The setup used to
perform all the experiments in shown in the Figure 2.7

33

Figure 2.7: Setup

2.4.2 Phantom Preparation
Phantoms were prepared using the powdered form of NADH and FAD from Sigma Aldrich
Inc. The part number for NADH is N8129 and the part number of FAD is F6625. Four
concentrations of NADH solution at 0uM, 70uM, 140uM, 280Um and FAD at 0uM, 40uM,
80uM, 160Um were prepared and placed in placed in a 96 well palette and imaging was
done. Solution and molecular weights of components used is shown in Table 2.5
The solution of desired Molarity was prepared per the formula shown below

MOLES OF SOLUTE

MOLARITY = LITERS OF SOLUTION
WEIGHT

MOLES OF SOLUTE = MOLECULAR WEIGHTT

34

(2.1)

(2.2)

Table 2.5: Solution used and Molecular weights
PARAMETER

VALUE

SOLUTION

0.1M HCL

MOLECULAR WEIGHT OF NADH

829.51

MOLECULAR WEIGHT OF FAD

709.40

A stock solution of NADH and FAD in 2.5ml Tris 0.1M HCL solution was prepared and
then further diluted to give the required concentrations. The part no of Tris 0.1M HCL is
T2319 Sigma Aldrich Inc. NADH of 4.2mM in 2.5 ml of Tris H.C.L was prepared and
then further diluted to get lower concentrations. Diluting 5 µL in 295 µL intra-lipid solution
(Intra-lipid + Ink) gave a concentration of 70 µM. Similarly, diluting 10 µL, 20 µL in 290
µL and 280 µL intra-lipid solution gave a concentration of 140 µM and 280 µM
respectively. Similarly, FAD of 2.4mM in 2.5 ml of Tris H.C.L was prepared and then
further diluted to get lower concentrations. Diluting 5 µL in 295 µL intra-lipid solution
gave a concentration of 40 µM. Similarly diluting 10 µL and 20 µL in 290 µL and 280 µL
intra-lipid solution gave a concentration of 80uM and 160 µM respectively.
The optical properties of Intra-lipid are shown in the Table 2.6.
Table 2.6: Optical properties of Intra-lipid
COEFFICIENT

VALUE (cm-1)

REDUCED SCATTERING

10

ABSORPTION

0.1
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2.4.3 Experiment
The camera based model is setup as described in the section 2.3.3 . Initially four
concentrations of NADH were placed in 96 well palette to form a square structure so that
the light from LED can evenly illuminate all the four concentrations. For NADH
reflectance the images were taken in 2x2 binning (Combining adjacent pixels in an image),
fluorescence mode with an acquisition time of five seconds. Similarly, FAD fluorescence
images were taken in 2x2 binning with an acquisition time of two and a half seconds. The
results are shown in Figures 2.8-2.11

Figure 2.8 : Reflectance of FAD

Figure 2.10 : NADH Reflectance

Figure 2.9 : Different concentrations of FAD

Figure 2.11 : Different concentrations of NADH
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The spectrum of these images is shown in the Figures 2.12,2.13

Figure 2.12 : FAD spectrum

Figure 2.13 : NADH spectrum

After acquisition, images are saved in .im3 file format. The images in .in3 format can be
opened by using the Multispectral imaging software only. The software also gives the
provision to select and portion of an image and visualize the spectrum of the selected
portion. This can be exported to Xcel and then MATLAB was used to perform data
analysis. It is also possible to extract a channel from the .im3 cube and save as .TIFF or
.JPEG image and perform image processing on it. For this experiment the channels at
which NADH and FAD gave peak were extracted and image processing was performed.

2.4.4 Image Processing
As mentioned in the previous section the peak channels were and processing was
performed on them. The following steps were done to perform image analysis. Initially the
reflectance image was selected and the four different concentrations were separated. The
same procedure was done to NADH and FAD fluorescence images. Next the reflectance
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image was divided with its corresponding fluorescence image for correction purposes. Next
the random pixel created by division (misalignment of the image) were removed. Results
are shown in the Figures 2.14,2.15

Figure 2.14: FAD image after image processing

Figure 2.15: NADH image after image processing
Finally, the mean of each concentration was taken and linearity curve was plotted. The
linearity curves for NADH and FAD fluorescence is shown in the Figures 2.16,2.17
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Figure 2.16: FAD linearity curve
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Figure 2.17: NADH linearity curve
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2.5 Ex-Vivo Experiments
In this section the experiments performed ex-vivo on mice placenta and cancer cells will
be discussed.

2.5.1 Measurement 0f FAD in Placenta
In this experiment, mice placentas were used to detect FAD fluorescence. The setup used
in the experiment is like setup shown in Figure with an excitation light of 450nm.
Experiment was performed on three placentas numbered 7-9 which is showed in the Figure
2.18.

Figure 2.18: Placenta

2.5.1.1 Results
The images were taken at integration time 2 seconds. As the aim of this study was to
determine the FAD signal from the sample, peak channel for FAD emission (520nm) and
excitation (450nm) were extracted from the image cube and image processing was
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performed on it and average of normalized fluorescence in each sample was calculated.
The results from the placenta is shown in the Figure 2.19,2.24.
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Figure2.19: Image cube

Figure 2.20: Spectrum
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Figure 2.21: Raw fluorescence
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Figure 2.22: Reflectance
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Figure 2.23: Normalized fluorescence
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Figure 2.24: Normalized fluorescence for each placenta
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From the resultant data, placenta number 9 had maximum fluorescence and that is since it
has less blood comparatively to placenta 7 and 8. Presence of blood increases reduces
fluorescence intensity. Whereas the fluorescence intensity from placenta 7 and 8 are close
to each other. This also shows that using a single fluorescence intensity as results may be
misleading and redox ratio is a better and accurate parameter.

2.5.2 Brain Cancer Cells
In this experiment cancer cells from brain were used to obtain the FAD redox ratio which
is defined as the ratio of FAD concentration to the summation of NADH and FAD
concentration. The setup used in the experiment is like setup shown in Figure with an
excitation light of 365nm. Brain cancer cells is shown in the Figure 2.25

Figure 2.25: Cancer cells

2.5.2.1 Results
The images were taken at integration time 2 seconds. As the aim of this study was to
determine the FAD redox ratio, peak channel for FAD (520nm), NADH (460nm) emission
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and excitation (410nm) were extracted from the image cube and image processing was
performed on it and average of redox ratio from the cancer cells was calculated. The results
from brain cells is shown in the Figure 2.26-2.30.
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Figure 2.26: Image cube

Figure 2.27: Spectrum-Cancer Cells

Figure 2.28: NADH-460nm

Figure 2.29: FAD-520nm
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Figure 2.30: Redox Ratio-Cancer Cells
Table 2.7: Mean and standard deviation of redox ratio – Cancer cells
REDOX RATIO

VALUE

MEAN

0.6297

STD

0.0016

The obtained redox ratio is close to the literature value [132].

2.5.3 Brain Normal Cells
Similar steps were performed for normal cells as described in section 2.52. Initially Image
cube was captures, peak emission of NADH and FAD was extracted from the image cube,
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image processing was performed on the extracted images and finally FAD redox ratio was
calculated. The results obtained are shown in the Figure

Figure 2.31: Normal cells

Figure 2.32: NADH-460nm

Figure 2.33: FAD-520nm
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Figure 2.34: Redox Ratio-Normal cells

Table 2.8: Mean and standard deviation of redox ratio – Normal cells
REDOX RATIO

VALUE

MEAN

0.4414

STD

0.0019

The obtained redox ratio is close to the literature value [132].

2.5.4 Comparison of Normal and Cancer Redox Ratio
This section gives a comparison of redox ratio in cancer cells when compared to normal
cells. Table 2.8 gives a comparison of redox ratio in both normal and cancer cells.
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Figure 2.35: Mean and standard deviation of redox ratio – Both cells

Table 2.8: Mean and standard deviation of redox ratio – Both cells
REDOX RATIO

NORMAL VALUE

CANCER VALUE

MEAN

0.4414

0.6297

STD

0.0019

0.0016

The obtained redox ratio is close to the literature value [132].

2.6 CONCLUSION
The camera based model is accurate, linear and can also detect low concentration value of
fluorophore. It provides an image of measurements which could be useful differentiate the
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diseased area in a normal tissue. The limitations of this model are that the setup is
expensive, occupied space and wired. To overcome these limitations a compact and
wireless model was designed which would be explained in the next chapter.
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Instrumentation and Results of Compact
Model
3.1 Introduction
As a metabolometer has the capability of detecting a number medical disorders, making a
compact, wireless and inexpensive device could serve several advantages. This chapter the
instrumentation of the compact and wireless fluorescence model will be discussed. The
aim was to make the device compact and low cost. The various parts used and the reason
for their selection will also be mentioned in this chapter.
Some previous works have been done to make the device compact. Chance et al made a
miniature Fluorescent Metabolometer to detect the fluorescence intensities and display
them on a LCD screen [145]. This model was compact but did not use any wireless
operation. Kornilin et al used a compact model to detect the auto fluorescence model from
the skin [146]. Another fluorescence detection model was built of a size of a pill which
could detect bleeding in the stomach [147].

3.1.1 Significance of Compact and Wireless Model
Mentioned in this section is the significance of the designed device over other instruments.
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3.1.1.1Compact and Light Weight
There are several advantages of having a compact device. The first one being, it could be
moved anywhere without the need of the patient to come to a specific location, like in most
of medical diagnoses. This could be very advantageous in cases of old, weak and patients
with mental disorders. Having compact and low weight makes a device wearable and could
be used to provide continuous monitoring of a person’s medical condition and this could
be particularly useful in military applications.

3.1.1.2Wireless
Having a wireless device also has several advantages. Having a wired device could limit
patient’s movement and could attract his/her attention during continuous monitoring [148].
Having wires in hospital environment could also lead tripping hazards [149]. Having wires
in a device would increase size and weight of a device [150]. Additionally, making a device
wireless and compatible with a mobile device could make the device use friendly and easy
to use.

3.1.1.3 Inexpensive Device
Building an inexpensive device could make the cancer detection possible even in
underdeveloped countries which do not have sufficient medical technology and
equipment’s to detect cancer. By building such device there is a possibility that the
mortality rate due to cancer in underdeveloped countries could be reduced.
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3.2 Instrumentation
In this section, all the electronics used for instrumentation of the small model will be
mentioned.

3.2.1 Light Source Unit
As the aim for the compact model was to make the device low cost, Light Emitting Diodes
(LED’s) were used as the source units for the device. These are usually cheap, compact
and are available in number of optical power specifications. The wavelength chosen for the
compact model was a 365nm LED from Marktech Optoelectronics Inc. The part number
of the LED is 1125-1254-ND. This wavelength was chosen as both NADH and FAD are
excited using this and to eliminate the use a second source unit
The specifications of the LED are shown in the Table 3.1
Table 3.1: Specifications of the LED
PARAMETER

VALUE

WAVELENGTH

365nm

SUPPLY VOLTAGE

3.5 V

SUPPLY CURRENT

100mA

OPTICAL POWER

54mW

The LED had a high optical power of 54mW at a forward current of 100mA. This optical
power is high for in vivo applications and was reduced by reducing the forward current.
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The spectrum and V-I characteristics of the LED are shown in Figure 3.1 and Figure 3.2.

Figure 3.1 : LED spectrum[151]

Figure 3.2 : V-I characteristics [151]

3.2.1.1 LED Driver
The LED driver used in this model is a constant current source. This is used to prevent the
fluctuations in current or voltage effect on the optical power illuminated form the LED.
This is important as fluctuations in the LED’s optical power can vary the fluorescence
emitted by the fluorophore which may lead to false diagnosis. To avoid these problems a
constant current source is used as a LED driver. This is constructed using a LM 317 I.C
chip from Texas Instruments. This is a voltage regulator and upon circuit design, this can
be converted to a constant current source where the output current depending upon the load
resistor. By using this I.C chip, LED would give a constant output irrespective of changes
in input voltage or current. While designing this constant current driver, it is important to
keep in mind that the power supply used in the circuit should be at least 2.5V greater than
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the forward voltage of the LED for its proper operation. The circuit used for the constant
current source is shown in the Figure 2.3.

Figure 3.3: Circuit of constant current source
Here the value of resistance R is chosen depending on the following equation

I (Current) =

1.25
R

(3.1)

3.2.1.2 Light Source Unit Testing
The most important testing of the source used for optical applications is its power or
stability testing. It is very important for the source to be very stable because variation its
power can lead to false positives during diagnosis. The LED stability testing is shown in
the Figure 3.4. Results of stability test is given in Table 3.2.
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Figure 3.4: Stability test for LED (Compact model)

Table 3.2: Stability test of LED (Compact model)
PARAMETER

VALUE

MEAN

47.85

STANDARD DIVIATION

182nW

3.2.1.3 Switching
The switch was used to turn on and off the LED on receiving the digital inputs from the
control unit. Initially Multiplexer was used to turn on and off the LED. The part number of
the multiplexer is CD54HC4052. This I.C chip on receiving digital inputs from the control
unit passes one of the inputs to the output. The pin diagram of the Multiplexer is shown in
the Figure 3.5.
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Figure 3.5: Pin configuration of multiplexer [152]
Relation between control signal and the input selection is shown in Table 3.3
Table 3.3: Relation between Control signal and the input selection
S0

S1

output

0

0

Input 1

0

1

Input 2

1

0

Input 3

1

1

Input 4

Multiplexer was used as a switch in the following fashion. The supply of the LED was
given to one of the inputs of the multiplexer and the other inputs of the multiplexer had no
connection. The terminals of the LED were connected at the Multiplexer’s output. On
providing the control signal (S0,S1) as (0,0) the LED would receive the supply and would
turn on. Upon receiving other signals, the supply would be disconnected from the LED and
would turn off. The drawback of the multiplexer was that due to its high resistance the
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input (constant current) passed onto the output (LED) dropped and LED could not receive
required voltage.
To avoid this problem Analog switch from Vishay electronics (Part number: DG 413) was
used to switch the LED. These were used as used two single-pole/single-throw (SPST)
analog switches. Each Analog switch IC has four individual switches. These switches had
a low input resistance thereby causing no voltage drop. Each switch has three pins, one is
the input which is the output of constant current source, second is the digital port which
was connected to the control unit and third was the output port which was connected to the
LED. On receiving high digital signal from the control unit, switch connects the input to
the output and upon receiving digital low it is disconnects the output from the input. In this
way, LED, can be turned on and off by communicating with the control unit.
The Pin configuration of the Analog switch is shown in the Figure 3.6

Figure 3.6: Pin configuration of analog switch [153]
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Table 3.4: Specifications of the Analog switch
PARAMETER

VALUE

SUPPLY VOLTAGE

Up to 45V

ON RESISTANCE

25 Ohm

SWITCHING TIME

110ns

3.2.2 Detector Source Unit
The detector chosen for the device is OPT 101 from Texas Instruments. It is an 8 pin Dip
Packaged I.C chip. The main advantage of this detector is that it has low noise, with good
sensitivity in the range of 450nm-800nm which is desirable. It also has a build in amplifier
whose gain can be varied by changing the loads resistor values.
The circuit for OPT 101 and its sensitivity is shown in the Figure 3.7,3.8 respectively.

Figure 3.7: Circuit of OPT 101[154]
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Figure 3.8: Sensitivity curve of OPT 101[154]

The pin configuration of OPT 101 is shown in the Figure 3.9.

Figure 3.9: Pin configuration of OPT 101[154]
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The specifications of the OPT 101 are shown in Table 3.5
Table 3.5: Specifications of Detector-OPT 101
PARAMETER

VALUE

SENSITIVITY AREA

2.2mm x2.2 mm

SENSITIVITY (NADH)

0.4

SENSITIVITY (FAD)

0.22

SUPPLY VOLTAGE (DUAL)
MAXIMUM DETECTION

0- +/- 15
SUPPLY-1.5V

3.2.2.1 Detector Source Unit Testing
The test conducted on the detector to test its sensitivity and stability was the linearity test.
In this test the water was taken in a cuvette, LED and detector were placed at right angles
that there is a minimal leakage from the light source in the detector unit. The fluorophore
used for the linearity test was fluorescein. The excitation wavelength of Fluorophore is
anywhere between 360nm-470nm and the emission peak is around 530nm. The fluorescein
solution used was taken from amazon. The part number of this product is B00WREOKIU.
This solution was taken and the light intensity was measured with no fluorescein, 1 drop,
2 drops and 3 drops of fluorescein. Then the leakage was deducted from the detected signal
to give a pure fluorescence signal. To prevent the leakage of light source onto the detector
a 500nm long pass filter was used from Thorlabs (Part number: FELH0500)
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The setup, fluorescence and the results are shown in the Figures 3.10, 3.11.

Figure:3.10 Small model setup

Figure 3.11: Fluorescence

The result of linearity test is given in the Table 3.6

Table 3.6: Linearity test (Compact Model)
CONCENTRATION

INTENSITY

NO CONCENTRATION

130Mv

1 DROP

620Mv

2 DROP

1170Mv

3 DROP

2260Mv
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The Linearity plot is shown in the Figure 3.12

Linearity
2500
R² = 0.966

Intensity in mV

2000
1500
1000
500
0
0

0.5

1

1.5

2

2.5

3

3.5

Number of drops

Figure 3.12: The Linearity Plot

3.2.2.2 Amplifier
The detector used in the device could give an amplification of about 1.1 x 10^7. If further
amplification was needed, then a post amplifier was used to provide further amplification.
The amplifier used in the device was an I.C TL072CP. This I.C chip provided the desired
amplification. It was possible to change the amplification provided by the Operational
Amplifier (Op-Amp) by slightly varying its circuit components. The pin configuration of
the I.C chip used is shown in the Figure.
The block diagram and pin configuration of the Operational amplifier is shown in the
Figure 3.13 and 3.14.
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Figure 3.13: Operational Amplifier [155]Figure 3.14: Pin Configuration of Op-Amp[155]

The specifications of the operational amplifier used in the design is shown in the Table 3.7
Table 3.7: Specifications of Operational Amplifier
PARAMETER

VALUE

SUPPLY VOLTAGE (DUAL)

-15 - +15

MAX AMPLIFIED VOLTAGE

+/- SUPPLY

AMPLIFICATION

-

Rf/Rin

3.2.2.3 Optical Filters
Filters were used in this setup to separate the signal emitted by NADH and FAD. Gelatin
filters form Gam Color were initially used to perform the separation. The part number of
the filters used in the device are Gold rush -388(FAD) and Orchid-955(NADH). The pass
spectrum of these filters is shown in the Figures 5.13-5.15
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The transmission data of Gelatin filters is shown in the Figures 3.15-3.17

Figure 3.15: Transmission data of Gold rush -388(FAD)[156]

Figure 3.16: Transmission data of Orchid -955(NADH). [156]

Figure 3.17: Transmission data of Heat Shield [156]
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Due to their low efficiency, there were not included in the device as they were not able to
efficiently separate the signals (NADH and FAD) and they also included a lot of light from
the excitation LED.
To avoid this, glass filters from Edmund optics were used to perform the separation. The
diameter of these glass filters was about 11.7mm. One glass filter centered at 460nm was
used to pass only the NADH signal to the detector and another filter centered at 520nm
was used pass only the FAD signal to the detector. The part number of the filters used are
62-083 (NADH) and 62-095(FAD). To avoid leakage from the source two layers of 400nm
long pass gelatin filters were placed on top of glass filters. The part number of this gelatin
filter from Gam-color is Heat Shield 99.

The pass spectrum of glass filters and heat shield is shown in the Figures 3.18,3.19.

Figure 3.18: Transmission data of 467nm bandpass filter [157]
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Figure 3.19: Transmission data of 515nm bandpass filter [158]

3.2.3 Control Unit
The control unit used in most of such applications is Data Acquisition Card (DAC) from
National Instruments. This is easy to use and has all the functionality of a perfect control
unit. The drawback of using a DAC is that it is expensive, has a larger size and would make
the device wired which is not desired. So, a microcontroller Atmel-Atmega32P (Arduino)
is used in place of a DAC unit. The advantage of using this microcontroller is that it is
inexpensive and have a considerable number of analog input, analog output and digital
lines sufficient for the application. The specifications of the Microcontroller are shown in
the Table 3.8.
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Table 3.8: Specifications of the Microcontroller
Microcontroller

ATmega328P

Operating Voltage

5V

Input Voltage (recommended)

7-12V

Input Voltage (limit)

6-20V

Digital I/O Pins

14

PWM Digital I/O Pins

6

Analog Input Pins

6

SRAM

2 KB

EEPROM

1 KB

Clock Speed

16 MHz

Length

68.6 mm

Width

53.4 mm

Weight

25 g

To control a microcontroller, a program was written on its software (ARDUINO 1.6.11)
and dumped on it. After dumping the code, the microcontroller would perform the desired
functionality. It also has transmission and reception ports which can be used for wireless
application. Another advantage of using microcontroller is that it has good ADC resolution
of about 5mV which is good when compared to the expensive Data Acquisition Card. In
addition to that the microcontroller has a regulated 5V and 3.3 V supply which can be used
as a power supply to other components in the device.

The Pin configuration of the microcontroller is shown in the Figure 3.20
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Figure 3.20: Pin configuration of Arduino [159]

3.2.4 Wireless Application
The device was made wireless using a Bluetooth module. The Bluetooth module used in
the device is HC-06. This module was chosen for wireless transmission because it is
compact and inexpensive. Another advantage of using HC-06 is that it can easily be
connected to any device having Bluetooth facility and data can be logged on the PC using
a Tera-term serial emulator which is available online for free or an application can be
created on android or IOS platform using which two-way communication can be done
between the Bluetooth module and a mobile phone. To use the Bluetooth module along
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with the microcontroller the program written on the microcontroller had to be modified by
including the header files of the Bluetooth module and the way you want wireless
communication to take place. The specifications of the HC-06 are shown in the Table 3.9.
Table 3.9: specifications of the HC-06
PARAMETER

VALUE

SUPPLY VOLTAGE

3.1-5V

FREQUENCY

2.4GHz

BAUD RATE

9600-38400

SIZE

27mm×13mm×2mm

On using the Bluetooth module with the microcontroller, it was possible to get around 140
digital converted values from a single detector or about 50-70 digital converted values from
two detectors which gave sufficient averaging.
The HC-06 is connected to the microcontroller as shown in the Figure 3.21

Figure 3.21: Connected of HC-06 with the microcontroller [160]
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3.2.5 Power Supply
As the aim was to make the device wireless, wall power supplies were not used to power
the device. Instead a couple of Lithium Ion batteries from Adafruit.com (Part number 1317)
were used. These Batteries are rechargeable and can be charged to a voltage of 3.7 V. A
couple of these batteries were connected in series to give a total voltage of 7.4V which was
used as a power supply to the detectors and the microcontroller. Providing a voltage of
about +/- 7.4 V DC to the detectors makes a maximum detectable range of the detectors to
+/-5V. All the other components in the device were powered using the 5v supply from the
Microcontroller. These Lithium Ion batteries were charged using the rechargeable kit from
Adafruit.com (Part number 2190).

The Li-ion battery and its charger are shown in Figure 3.22

Figure 3.22: Battery and charger
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3.2.6 Display
The following were used to display the values detected by the device.

3.2.6.1 Liquid Crystal Display
Liquid Crystal Display (LCD) was initially used to display the results obtained from the
device. The idea was not to use wireless communication and directly display the digital
values converted by the microcontroller onto the LCD screen. The LCD screen selected for
this was taken from Adafruit.com (Part no: 198) and was 20 X 4 LCD screen. To use the
LCD, the program written onto the microcontroller was modified by adding specific details
and headers of the LCD screen. Next the way results are to be displayed was also include
in the program.
The connection between the LCD and microcontroller is shown in the Figure 3.23

Figure 3.23: Connection between LCD and microcontroller [161]
The results obtained and dis-played on the LCD screen is shown in the Figure 3.24
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Figure 3.24: Display on LCD screen

3.2.6.2 Wireless Bluetooth Display
Using a Bluetooth module with the device made possible to connect it to any device having
Bluetooth facility.

3.2.6.2.1 Tera-Term
On a personal computer, downloading a Tera-Term terminal made it easy to communicate
with the device. It was possible to give instructions to the device and to take results from
the device. The panel of Tera-Term emulator is shown in the Figure 3.25.

Figure 3.25: Tera Term terminal
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3.2.6.2.2 LABVIW
A Lab-view code was also written to get the values form Bluetooth and display the realtime values. The front panel of the Lab-view code is shown in the Figure 3.26

Figure 3.26: Lab-view front panel

3.2.6.2.3 Mobile Application
As the device, could send the data wirelessly to any device having Bluetooth, a mobile
application on Android platform was used to avoid the usage of P.C, give commands and
record the measurements on a mobile phone. The mobile application was user friendly and
the user only had to decide the acquisition time and the detected data would be saved as a
text file on the mobile phone indicating the results. The mobile application used is the
Bluetooth serial controller available on Android platform for free. The panel of this
application is shown in the Figure 3.27
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Figure 3.27: Mobile application

3.2.7 Post Processing
In this application, a lot of post processing was not used as the results directly indicated
the fluorescence values detected by the detector. When Lab-view code was used, the
program included the post processing section which gave the average of detected values.
In the case of results obtained from Mobile application and Tera-term emulator, they were
stored as an Xcel file and the average of results was taken either in Excel directly or
MATLAB.
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3.3 Block Diagram
The block diagram of the complete setup is shown in the Figure 3.28

Figure 3.28: Block diagram of compact model

3.4 3d Printed Patch
The patch used to hold the source and detectors was designed using Fee-Cad software and
printed using a 3D printer. The patch was designed such that it had outlets for the source
(LED) and detector coupled with filter. The patch has straps on either side which can be
firmly attached to the detecting surface and thereby avoiding any stray light getting into
the detectors. Due to size restrictions, the source-detector separation no less than 1 cm was
obtained. The 3D printed patch is shown in the Figure 3.29
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Figure 3.29: Patch

3.5 Experiment and Result
The efficiency of the device was tested by its ability to differentiate the concentrations of
NADH and FAD in normal tissue to that of cancer tissue as shown in the paper [132]. Per
this, a normal tissue has a mean concentration of NADH and FAD as 84um and 83um
respectively. Whereas a normal tissue has a mean concentration of NADH and FAD is
308um and 217um respectively. For these concentrations, FAD redox ratio which is the
ratio of FAD fluorescence intensity to the sum of FAD and NADH fluorescence intensity
was calculated. For normal tissue a mean redox ratio value of 0.44 was obtained and for a
cancer tissue a redox ratio value of 0.56 was obtained.
To perform a similar study Tonic water (Quinine) was used in place of NADH which has
similar excitation-emission wavelength to NADH. Similarly, Fluorescein was used in place
of FAD because of its similar fluorescence properties. Fluorescein also gets excited at a
couple of wavelengths 365nm, 450nm and has an emission peak at 530nm. These
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fluorophores were used for preliminary testing as NADH and FAD are expensive drugs.
On the contrary fluorescein and quinine have different molar excitation coefficient and
quantum yield compared to NADH and FAD. To make them comparable for the
experiment the concentration of fluorescein and quinine were reduced to mimic the molar
excitation coefficient and quantum yield of FAD and NADH respectively.
After making the parameters of fluorescein and quinine equivalent to NADH and FAD,
concentration of quinine and fluorescein in normal tissue was 6um and 14um respectively.
Whereas for a cancer tissue the concentration of quinine and fluorescein in normal tissue
was 14um and 52um respectively. These concentrations were added to the prepared
phantom and the fluorescence emitted by them was recorded.
In this experiment phantom used had optical properties us’ as 10cm-1 and absorption
coefficient as 0.1cm-1. Scattering was introduced into the phantom by adding 20% intralipid solution and absorption was introduced by adding Indian ink to the water. After
phantom of desired optical properties was made, the required concentration of quinine and
fluorescein were added and fluorescence was detected by the detectors. The detector
coupled with a 460nm Band Pass Filter detected quinine and the detector coupled with a
580nm Band Pass Filter detected fluorescein. The acquisition time was set to 2000ms and
the detected value was averaged to give the net fluorescence value. Finally, the
fluorescence detected by the device at normal concentration to cancer conditions were
compared and R.R was calculated.
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The setup used in the experiment is shown in the Figure 3.30

Figure 3.30: Setup of compact model

The complete setup is shown in the figure 3.31

Figure 3.31: Compact Device
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Figure 3.32: Patch

Figure: 3.33: Fluorescence

Finally, the detected fluorescence shown in the Figure 5.30 was corrected for peak and
sensitivity. So, the resultant redox ratio for a normal tissue and cancer tissue was 0.515
and 0.617 respectively. Per previous study the mean value of redox ratio normal tissue and
cancer tissue was 0.44 and 0.56 respectively [132]. The results obtained by the device are
off by 9-15% but is still within the standard deviation of the study. The comparison is
shown in Table 3.10.

Table 3.10: Results from compact model
TISSUE (R.R)

PAPER [132]

COMPACT MODEL

% ERROR

NORMAL

0.44

0.515

14

CANCER

0.56

0.617

9
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3.6 Conclusion
The designed explained in this chapter is wireless, compact and inexpensive. The design is
also accurate and can detect concentrations to about 4µM. The limitation of this compact
model was the large source-detector separation distance. The presence of glass filters
restricted the source-detector separation distance not less than 1 cm which prevented the
device from measuring very low concentrations. Even if the glass filters were removed and
cut to exactly fit onto the detector surface then the source-detector separation would be
around 6mm which is not a huge difference. The minimum concentration that could be
detected by the compact device was around 6µM of NADH. To detect even lower
concentrations a third design was used which will be explained in the next chapter.
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Instrumentation

and

Results

of

Spectrometer Based Model
4.1 Introduction
To overcome the problems of large source detector separation distance and small
concentration measurement in the compact module an alternative devised using a
spectrometer which could possibly overcome all the drawbacks of the compact model
discussed in the previous chapter.
The study of the interaction of matter with electromagnetic radiation is known as
Spectroscopy [162-163]. Biomedical spectroscopy is done by measuring the interaction
between light and tissue, which provides a variety of information of the tissue [164].

4.2 Instrumentation
In this section, all the components used for the instrumentation of the modified small
fluorescence model will be mentioned
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4.2.1 Light Source Unit
The LED used for the modified design was a fiber coupled LED from Mightex Inc. The
part number of this LED is FCS-0365-000. The wavelength chosen for this model was a
365nm as both NADH and FAD could be excited using this and would eliminate the use a
second source unit. The main advantage of using this LED was that it was compact, fiber
coupled and not very expensive
The specifications of the LED are shown in the Table 4.1 and spectrum in Figure 4.1.

INTENSITY

Table 4.1: Specifications of the LED (Spectrometer model)
PARAMETER

VALUE

WAVELENGTH

365nm

SUPPLY VOLTAGE

3.7 V

SUPPLY CURRENT

500mA

OPTICAL POWER

18mW

10000
9000
8000
7000
6000
5000
4000
3000
2000
1000
0
300

350

400

WAVELENGTH

Figure 4.1: LED spectrum
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4.2.1.1 LED Driver
The driver used to run the LED was constant current source and was taken form Digi-key
(part number 945-1122-ND). This supply gave a constant current to the LED of
500mA.The Specifications of the constant current driver is shown in the Table 4.2
Table 4.2: Specifications of the LED driver (Spectrometer model)

PARAMETER

VALUE

WAVELENGTH

365nm

SUPPLY VOLTAGE

4.5-36V

OUTPUT VOLTAGE MAX

500mA

OUTPUT VOLTAGE MAX

2-35V

The pin configuration of LED driver is shown in the Figure 4.2

Figure 4.2: Pin configuration of led driver [165]
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The connection from the LED driver to the LED is shown in the Figure 4.3.

Figure 4.3: Connection from LED driver to the LED [165]

4.2.1.2 Light Source Unit Testing
The most important testing of the source used for optical applications is its power or
stability testing. It is very important for the source to be very stable as variation its power
can lead to false positives during diagnosis. Thus, it is very important that the source should
be highly stable. The result is shown in the Figure 4.4 and Table 4.3.

Figure 4.4: LED stability test (Spectrometer model)
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Table 4.3: Stability test of LED (Spectrometer model)
PARAMETER

VALUE

MEAN

6223counts

STANDARD DIVIATION

36.9 counts

% ERROR

0.5

4.2.1.3 Switch
The switch used in this version is the same switch (Vishay: DG-413) used for the compact
model explained in section 3.2.1.3. The input of the switch was the LED driver. As each
switch has three pins, one is the input which is the output of LED driver, second is the
digital port which was connected to the control unit and third was the output port which
was connected to the LED. In this way LED, can be turned on and off by communicating
with the control unit.

4.2.2 Detector Source Unit
The detector used for this design was STS spectrometer from Ocean Optics. The advantage
of using a spectrometer is that it is very sensitive, fiber based and ultra-compact. The only
disadvantage of spectrometer was that it was a little expensive. The specifications of the
spectrometer are shown in the Table. Sensitivity solves the problem of lower concentration
detection and fiber based solved the problem of large source-detector separation. The
specifications of the STS spectrometer are shown in Table 4.4.
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Table 4.4: Specifications of the Spectrometer
PARAMETER

VALUE

WAVELENGTH RANGE

350-800nm

OPTICAL RESOLUTION

12nm

DYBAMIC RANGE

5 x 109

INTEGRATION TIME

10 µs to 10
s
14 bits

ADC RESOLUTION

The sensitivity curve of the spectrometer is shown in the Figure 4.5

Figure 4.5: Sensitivity curve of spectrometer- oceanoptics.com

4.2.2.1 Detector Unit Testing
The spectrometer was tested to see the minimum detectable concentration it could measure.
This experiment was done by measuring the fluorescence emitted by fluorescein. A stock
solution of fluorescein was made using its powdered form (Sigma Aldrich: 518-47-8). This
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was further diluted to make lower concentrations. The prepared solution was excited using
the 365nm LED and the fluorescence emitted by it was measured on the spectrometer. The
experiment setup is shown in the Figure 4.6.

Figure 4.6: Experimental Setup of spectrometer based model

The experiment started with the fluorophore concentration in micro molar range and the
concentration was reduced to Nano molar range. The instrument could measure up to 5uM
with an integration time of 100ms. An integration time of 1 second was used to measure
the concentration in Nano molar range and the instrument could measure a concentration
of 2nM. It is possible to set the integration time of spectrometer up to 10 seconds and take
the measurements. So, experiment was stopped at this point as from the data obtained it
was clear that the device could measure concentration lower than 2nM.
The results obtained from the experiment is shown in Figure 4.7.

87

Linearity Testing
3500
R² = 0.9901

Light Intesity

3000

2500
2000
1500
1000
500
0

0

10

20
30
Concentration (uM)

40

50

Figure 4.7: Linearity in Micro molar range with integration time 100ms
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Figure 4.8: Linearity in Nano molar range with integration time 1s
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4.2.3 Wireless Application
The following components were used for the wireless transmission of data from the
spectrometer to the P.C / Laptop / Mobile device.

4.2.3.1 Raspberry Pi
The control unit used for transmitting the signal from the spectrometer to the P.C and giving
digital signal to the analog switch is a Raspberry Pi. This is a smallest form of processing
unit available which works on Linux operating system. The specifications of the Raspberry
Pi are shown in the Table 4.5
Table 4.5: Specifications of the Raspberry Pi
PARAMETER

VALUE

RAM

1GB

PROCESSOR

900MHz

USB PORTS

4

GPIO PINS

40

MIN SUPPLY CURRENT

700mA

A spectrometer and WIFI dongle were connected to the USB ports of Raspberry Pi and the
one of the general-purpose input/output (GPIO) pin of the Pi was given to the analog switch
to turn on and off the LED.
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4.2.3.2 WIFI
A WIFI dongle was attached to one of the ports of the Raspberry pi to transmit the data
wirelessly from the Raspberry Pi to the control device and vice versa. The WIFI dongle
used had a speed of 150Mbps. This enabled to control the design with any device having
WIFI facility. To control the spectrometer and LED from the control device a program was
written in .HTML and two webpages were created which are shown in Figure 6.8 and 6.9.
One webpage was used to control the spectrometer and this program was taken from ocean
optics. The other webpage was used to turn on and off the LED. A screenshot of the
webpages used to control the Spectrometer and LED are shown in the Figure 49,4.10

Figure 4.9: Screensoot of Spetrometer webpage (Ocean Optics)
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Figure 4.10: Screensoot of LED webpage

4.2.4 Power Supply
The power supply initially used to power the device was a portable power supply form
Ocean-optics (Part: CM-5095-WE). The specifications of the power supply are shown in
Table 4.6.
Table 4.6: Specifications of the Power supply from Ocean Optics
PARAMETER

VALUE

VOLTAGE

5V

CURRENT

1A

CAPACITY

3000mAh

This power supply was given to the Raspberry Pi and the Spectrometer, WIFI dongle
received power from its USB ports and the power supply could power all of them without
any problem. When the 5V supply of Raspberry Pi was given to the LED driver to run the
LED but the power supply did not have sufficient current to power up all the components.
To overcome the problem of current deficiency this power supply was replaced by another
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Jackery power supply taken from Amazon.com (Part number: B00AANMVNQ). This
solved the problem of insufficient current. The specification of the power supply form
Jackery is shown in the Table 4.7.
Table 4.7: Specifications of the Power supply from Jackery
PARAMETER

VALUE

VOLTAGE

5V

CURRENT

2A

CAPACITY

6000mAh

Two paths were taken from the output of the supply and one was given to Raspberry Pi and
the other was given to the LED driver.

4.3 Block Diagram
The block diagram of the complete setup is shown in the Figure 4.11.

Figure 4.11: Block diagram of spectrometer model
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4.4 3D Printed Module
A module was designed using AutoCAD software and 3D printed to fit all the components
of the spectrometer model in a small box. The box also had openings for spectrometer and
LED using which fibers of different diameters can be attached before taking the
measurements. It also had slits to turn on the module, charge the battery, show the charge
of the battery and for cooling purpose.

Figure 4.12: Front and side view of the spectrometer module

Figure 4.13: Top view of spectrometer module
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Figure 4.14: Handheld device

4.5 Ex-Vivo Experiment
In this section the experiments performed ex-vivo on mice placenta and cancer cells will
be discussed.

4.5.1 Measurement 0f Redox Ratio in Placenta
In this experiment, mice placentas were used to detect FAD redox ratio. The setup used in
the experiment is shown in the Figure
Experiment was performed on three placentas numbered 7-9 which is showed in the Figure
4.15.

Figure 4.15: Placenta

4.5.1.1 Results
Several measurements were performed on each placenta and average of these readings
were divided by LED leakage to obtain the spectra for each placenta. This spectrum was
used to extract the NADH (460nm) and FAD (520nm) excitation band. The results are
shown in Figure 4.16,4.17.
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Figure 4.16: Extracted values of NADH and FAD
The extracted NADH and FAD values were used to obtain the FAD redox ratio which is
given as shown below

FAD REDOX RATIO =

FAD
FAD+NADH

0.6

Redox Ratio

0.5
0.4
0.3
0.2
0.1
0
7

8
PLACENTA

Figure 4.17: Redox ratio of each sample
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9

These results are like camera based model which shows placenta 9 had maximum
fluorescence since it has less blood comparatively to placenta 7 and 8. Presence of blood
increases reduces fluorescence intensity. Whereas the fluorescence intensity from placenta
7 and 8 are close to each other.

4.5.2 Brain Cancer Cells
In this experiment cancer cells from brain were used to obtain the FAD redox ratio. The
setup used in the experiment is like Figure 4.9,410. Brain cancer cells is shown in the
Figure 4.18.

Figure 4.18: Cancer cells

4.5.2.1 Results
Several measurements were performed on cancer cells and the medium in which they were
grown and their average was divided to remove the any auto fluorescence from the
medium. This ratio gave the final spectrum. This final spectrum was used to extract the
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NADH (460nm) and FAD (520nm) excitation band. The results are shown in the Figures
4.19,4.20.

NADH

FAD

Figure 4.19: Normalized fluorescence signal-Cancer cells
The extracted values of NADH and FAD is shown in the Figure 4.18

3000

FLUOROPHORE CONCENTRATION
NADH

2000
1000
0
BRAIN CANCER CELLS
Figure 4.20: Extracted NADH and FAD- Cancer cells
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FAD

FAD REDOX RATIO =

FAD
FAD+NADH

Table 4.8: Mean and standard deviation of redox ratio – Cancer cells
REDOX RATIO

VALUE

MEAN

0.6116

STD

0.0183

These values are very like the camera based model and literature [132].

4.5.3 Brain Normal Cells
A similar process was performed like section 4.5.3 and FAD redox ratio of normal cells
was calculated

Figure 4.21: Normalized fluorescence signal-Normal cells
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Figure 4.22: Extracted NADH and FAD- Normal cells

Table 4.9: Mean and standard deviation of redox ratio -Normal Cells
REDOX RATIO

VALUE

MEAN

0.44001

STD

0.022

These values are very like the camera based model and literature [132].
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4.5.4 Comparison of Camera Model and Spectrometer Model
The results obtained from both the instruments are shown in Table 4.10
Table 4.10: Redox ratio comparison
CELLS

CAMERA MODEL

SPECTROMETER MODEL

CANCER

0.6297± 0.0016

0.6116± 0.0183

NORMAL

0.4414± 0.0019

0.4400± 0.022

The Figure 4.23 below shows the comparison of camera based model and compact model

COMPARISON
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0
CANCER
CAMERA

NORMAL
SPECTROMETER

Figure 4.23: Comparison between camera system and compact spectrometer system
As it is seen from the plot the values of the redox ratio obtained with camera based
system and compact spectrometer system are very similar.
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4.6 Conclusion
The spectrometer model is slightly larger in size but a lot more sensitive compared to the
compact model explained in previous chapter. This design can detect low fluorophore
concentration unlike the compact model. The sensitivity of the of the spectrometer model
is in comparison to the camera model which is evident from the close redox ratio obtained
from the brain cells.

4.7 Comparison of Three Systems
The Table 4.11 shows the comparison of all the three models used.

Table 4.11: Comparison of modalities
PARAMETER

CAMERA BASED
SYSTEM

COMPACT MODEL

SPECTROMETER
MODEL

SENSITIVITY

VERY HIGH

MODERATE

HIGH

PORTABLITY

NO PORTABILITY

HIGH PORTABILITY

HIGH PORTABILITY

COST

VERY HIGH

VERY LOW

LOW
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